Authors: Brantley-Sieders, Dana; Schmidt, Sonja; Parker, Monica; Chen, Jin

Source: Current Pharmaceutical Design, Volume 10, Number 27, October 2004 , pp. 3431-3442(12)

Publisher: Bentham Science Publishers

Abstract:

Eph receptors are a unique family of receptor tyrosine kinases (RTK) that play critical roles in embryonic patterning, neuronal targeting, and vascular development during embryogenesis. In adults, Eph RTKs and their ligands, the ephrins, are frequently overexpressed in a variety of cancers and tumor cell lines, including breast, prostate, non-small cell lung and colon cancers, melanomas, and neuroblastomas. Unlike traditional oncogenes that often function only in tumor cells, recent data show that Eph receptors mediate cell-cell interaction both in tumor cells and in tumor microenvironment, namely the tumor stroma and tumor vasculature. As such, Eph RTKs represent attractive potential targets for drug design, as targeting these molecules could attack several aspects of tumor progression simultaneously. This review will focus on recent advances in dissecting the role of Eph RTKs in tumor cells, tumor angiogenesis, and possible contribution to trafficking of inflammatory cells in cancer.

Keywords: eph receptors; receptor tyrosine kinases; ligands; signaling; cancer cells; tumor cells; tumor microenvironment; tumor anglogenesis

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1381612043383160

Affiliations: 1: A-4323, MCN, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.

Publication date: 2004-10-01

More about this publication?

• Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
  
  Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Brantley-Sieders, Dana ;  Schmidt, Sonja ;  Parker, Monica ;  Chen, Jin

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers